Research ArticleCancer

A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates

See allHide authors and affiliations

Science Translational Medicine  27 May 2015:
Vol. 7, Issue 289, pp. 289ra82
DOI: 10.1126/scitranslmed.aaa5693

Log in to view full text


Navigate This Article